PTC Therapeutics | PTCT - Caixa e Equivalentes





Caixa e Equivalentes Alterar Data
Acadia Pharmaceuticals USD 851.46M 31.77M 2026-03
Alnylam Pharmaceuticals USD 1.71B 53.53M 2026-03
Amgen USD 12.04B 2.91B 2026-03
BioCryst Pharmaceuticals USD 171.59M 164.32M 2026-03
Biogen USD 3.38B 374.2M 2026-03
BioMarin Pharmaceutical USD 2.22B 910.76M 2026-03
Cytokinetics USD 129.84M 7.32M 2026-03
Daiichi Sankyo JPY 542.16B 97.68B 2025-09
Enanta Pharmaceuticals USD 37.44M 5.14M 2025-12
Esperion Therapeutics USD 156.16M 11.69M 2026-03
Gilead Sciences USD 7.56B 234M 2025-12
Incyte USD 4.02B 435.22M 2026-03
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
Ironwood Pharmaceuticals USD 220.47M 5.01M 2026-03
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
Novartis USD 6.88B 4.56B 2026-03
Pfizer USD 1.7B 561M 2026-03
PTC Therapeutics USD 833.99M 150.66M 2026-03
Puma Biotechnology USD 53.52M 1.14M 2025-09
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sarepta Therapeutics USD 464.45M 336.83M 2026-03
TG Therapeutics USD 442.21M 242.7M 2026-03
Ultragenyx Pharmaceutical USD 175M 246M 2026-03
Vertex Pharmaceuticals USD 7.25B 638.6M 2026-03
Xencor USD 14.17M 39.9M 2026-03